Added to YB: 2026-06-11
Pitch date: 2026-06-09
CLPT [bullish]
ClearPoint Neuro, Inc.
+1.55%
current return
Author Info
Triple S is a professional special situations investor who shares ideas in their newsletter. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$407.6M
Pitch Price
$13.54
Price Target
N/A
Dividend
N/A
EV/EBITDA
-19.79
P/E
-13.45
EV/Sales
10.72
Sector
Health Care Equipment and Supplies
Category
growth
Free Demo of New Special Situations Tool and Stock Trade Compilation Episode Ocho - $CLPT
CLPT (sold puts): Sold 10 puts on ClearPoint Neuro, MR-guided brain intervention platform play. Asymmetric driver: uniQure's Huntington's candidate AMT-130—CLPT supplies ~$20K disposables/infusion on potential FDA approval. 60+ biopharma partners; new Velocity Alpha drill 510(k)+CE Mark.
Read full article (1 min)